BioTrinity 2025 will be held from the 1st – 2nd April in London, UK.

Now in its 19th year, OBN’s flagship two-day conference for the life sciences industry is set to feature a showcase of presentations from R&D companies across 14 different therapy areas, a packed business & investment track, sponsors exhibition, networking events, private partnering meetings and an academic poster presentation. The event brings together a mix of early stage and emerging life sciences R&D companies, investors, big pharmaceutical companies, academics, charities, government, and a broad range of valued service providers, with delegates attending from around the UK, Europe, USA, Japan, China and Australia.

Dehns Biotechnology Partner Christopher (Kit) Wilkins will be attending.

Please contact us if you would like to organise a meeting.